[ad_1]
Ivermectin is known by the medical community in our country and, although it is an antiparasitic drug, it is included in the protocols for the treatment of COVID-19. The drug is believed to help in the early stages of the disease. It should be clarified that the situation is dynamic and that there is no single protocol for the treatment of coronavirus. There will be one in four or five years. “Thus, the president of the health and social commission of the Sofia City Council, Dr. Anton Koychev, commented to kmeta.bg medicines used to treat coronavirus.
He added that this drug has long been used to treat scabies, but it also works for COVID-19. Koychev recalled that Remdisivir, which was developed to treat Ebola, was also included in the protocols to treat the virus, but it did not help in all cases.
The head of the Sofia City Council’s health commission said the question with vaccines is how effective they will be in large groups of people, and not just in those on whom clinical trials have been conducted.
Prof. Ivo Petrov: Vaccines will save billions of people
The tests have been done on tens of thousands of people, but when used widely, it affects millions of people. According to Koychev, RNA vaccines are the most modern because they directly introduce RNA particles and develop immunity.
Adenovirus vaccines are another type: adenovirus is used as a vehicle, a part of the coronavirus spike membrane is inserted into the cell membrane, and immunity develops again. RNA vaccines are fairly insured against side effects because they do not affect human DNA, Koychev said. He clarified that for the different vaccines there are re-immunization requirements to ensure the duration of the effect. This means that a second immunization is given between day 19 and day 21.
READ ALL ABOUT CORONAVIRUS IN OUR COUNTRY AND THROUGHOUT THE WORLD HERE
To be the first to know news from Bulgaria and the world, download the new NOVA app – for Android HERE or iOS (Apple) HERE.
Subscribe FREE to the nova.bg newsletter HEREto receive the most important news of the day in your email.
[ad_2]
